Enveric Biosciences, Inc. (ENVB) vs Kiora Pharmaceuticals, Inc. (KPRX)

Enveric Biosciences, Inc. and Kiora Pharmaceuticals, Inc. are both Biotechnology companies. Enveric Biosciences, Inc. and Kiora Pharmaceuticals, Inc. are of similar size ($6.6M and $6.3M). Kiora Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 983.7% against −13.9%. Across the 14 metrics below, Kiora Pharmaceuticals, Inc. leads on 8 and Enveric Biosciences, Inc. on 6.

Valuation

Metric ENVB KPRX Biotechnology median
P/E n/m n/m 10.60
P/S 0.16 0.47 9.40
P/B 0.70 0.52 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.27 0.62 0.66
EV/Sales (0.07) (0.42) 9.02
Earnings yield (1,322.27%) (174.20%) (32.88%)
Free cash flow yield (188.36%) (98.19%) (23.13%)

Profitability

Metric ENVB KPRX Biotechnology median
Gross margin 0.00% 85.06% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (235.48%) (56.36%) (51.96%)
Return on assets (193.53%) (39.43%) (46.06%)
Return on invested capital 0.00% (44,053.91%) 0.00%

Growth

Metric ENVB KPRX Biotechnology median
Revenue growth (TTM) (13.93%) 983.73% 6.76%
EPS growth (last fiscal year) 84.14% (403.45%) 29.88%
Revenue growth, 5-year CAGR — 88.72% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ENVB KPRX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 10.21 8.97 4.97
Net debt to EBITDA 0.55 1.33 1.01

Dividend

Metric ENVB KPRX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ENVB KPRX Biotechnology median
Market cap 6.26m 6.63m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack